Watch new code descriptors for the terms ‘booster’ and ‘third dose.’ On Dec. 8, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines. Healthcare providers can now administer these boosters to patients 6 months of age and older. Here’s how to code the supply […]
The post FDA Updates EUAs for Pediatric Bivalent Vaccines appeared first on AAPC Knowledge Center.